-
Symbol
-
TRDA on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.0001 per share
-
Latest Disclosed Shares Owned
-
2,569,115 shares
-
Security Ownership %
-
6.9%
Roche Finance Ltd ownership in Entrada Therapeutics, Inc. Common Stock, par value $0.0001 per share (TRDA)
14 Feb 2025 - Roche Finance Ltd has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,569,115 shares of Entrada Therapeutics, Inc. Common Stock, par value $0.0001 per share (TRDA).
This represents 6.9% ownership of the company.
This is the first filing by ROCHE FINANCE LTD disclosing ownership of Entrada Therapeutics, Inc. Common Stock, par value $0.0001 per share (TRDA).